Telomerase Inhibitors as Anticancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5968|2|5|567-575

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.2, Iss.5, 2002-01, pp. : 567-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone Deacetylase Inhibitors and Anticancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 4, 2002-07 ,pp. : 477-484

Bentham Science Publishers

Access to resources Recommend Favorite

Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 3, 2016-08 ,pp. : 297-308

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Biogenesis Inhibitors for Anticancer Therapy: A Review of Recent Patents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 11, Iss. 3, 2016-08 ,pp. : 332-341

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Telomerase for Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 7, Iss. 3, 2011-08 ,pp. : 215-226

Bentham Science Publishers

Access to resources Recommend Favorite

1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 14, 2018-02 ,pp. : 1869-1883

Bentham Science Publishers

Access to resources Recommend Favorite